Radiopharm Theranostics
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WALists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 30/08/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1547th | Radiopharm Theranostics | -59% |
1746 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 839th |  | Radiopharm Theranostics | $6.2m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
 | NEWS: Tagged in Radiopharm ups stake in US cancer-fighting venture | 26 Aug 2024 |
| NEWS: Tagged in US medical guru jumps into Radiopharm cancer fight | 20 Aug 2024 |
| NEW ROLE: Leila Alland, Non-Executive Director | 07 Aug 2024 |
| NEW ROLE: Hester Larkin, Non-Executive Director | 07 Aug 2024 |
| NEW ROLE: Riccardo Canevari, Chief Executive Officer, Managing Director | 07 Aug 2024 |
| NEW ROLE: Riccardo Canevari, Chief Executive Officer, Managing Director | 07 Aug 2024 |
| NEW ROLE: Ian Turner, Non-Executive Director | 07 Aug 2024 |
| NEW ROLE: Phillip Hains, Chief Financial Officer, Joint Company Secretary, Non-executive director | 07 Aug 2024 |
| NEWS: Tagged in Radiopharm banks US$2m in sales to American medical giant | 05 Aug 2024 |
| NEWS: Tagged in Radiopharm gets crucial nod for brain cancer imaging trial | 23 Jul 2024 |
